6:33 PM
 | 
Oct 15, 2012
 |  BC Extra  |  Clinical News

HCV data buoys BMS

Shares of Bristol-Myers Squibb Co. (NYSE:BMY) gained on Monday on the release of an abstract of Phase IIa HCV data slated for presentation at November's American Association for the Study of Liver Diseases meeting in Boston. An all oral regimen of...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >